Percutaneous transluminal coronary angioplasty and the changing indications for coronary artery bypass grafting for single-vessel coronary artery disease.

[1]  L. T. Sheffield,et al.  Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery. The Coronary Artery Surgery Study (CASS) , 1990, Circulation.

[2]  H. Schaff,et al.  Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. , 1990, Circulation.

[3]  E. Jones,et al.  Changing use of coronary angioplasty and coronary bypass surgery in the treatment of chronic coronary artery disease. , 1990, The American journal of cardiology.

[4]  F. Loop,et al.  Late follow-up of 781 patients undergoing percutaneous transluminal coronary angioplasty or coronary artery bypass grafting for an isolated obstruction in the left anterior descending coronary artery. , 1989, American heart journal.

[5]  E. Jones,et al.  Trends in invasive treatment of single-vessel and double-vessel coronary disease. , 1988, The Journal of thoracic and cardiovascular surgery.

[6]  W. C. Sheldon,et al.  Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. , 1986, The New England journal of medicine.

[7]  E. Varnauskas.  Survival, myocardial infarction, and employment status in a prospective randomized study of coronary bypass surgery. , 1985, Circulation.

[8]  David O. Williams,et al.  Relative cost of coronary angioplasty and bypass surgery in a one-vessel disease model. , 1984, The American journal of cardiology.

[9]  L. Campeau.  Letter: Grading of angina pectoris. , 1976, Circulation.